1701 — China Chemical & Pharmaceutical Co Balance Sheet
0.000.00%
Last trade - 00:00
- TWD6.49bn
- TWD9.48bn
- TWD8.57bn
- 60
- 53
- 19
- 37
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 776 | 1,035 | 946 | 852 | 489 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,424 | 2,440 | 2,321 | 2,554 | 2,459 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 5,498 | 5,927 | 5,567 | 5,939 | 5,583 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4,352 | 4,365 | 4,252 | 4,299 | 4,541 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 11,578 | 12,357 | 12,787 | 12,823 | 12,865 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3,032 | 3,313 | 2,807 | 3,300 | 3,393 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 5,671 | 5,765 | 5,033 | 5,430 | 5,432 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 5,906 | 6,592 | 7,754 | 7,393 | 7,432 |
Total Liabilities & Shareholders' Equity | 11,578 | 12,357 | 12,787 | 12,823 | 12,865 |
Total Common Shares Outstanding |